Pramodini Medicare Limited (NSE:PRAMODINI)
India · Delayed Price · Currency is INR 111.05
-0.35 (-0.31%)
At close: Oct 22, 2026
Pramodini Medicare Revenue
In the fiscal year ending March 31, 2026, Pramodini Medicare had annual revenue of 622.88M INR with 62.90% growth. Pramodini Medicare had revenue of 178.35M in the quarter ending March 31, 2026. That makes Pramodini Medicare the 39,019th largest company in the world by revenue and 3,591st in India.
Revenue
622.88M
Revenue Growth
+62.90%
P/S Ratio
3.85
Revenue / Employee
3.87M
Employees
161
Market Cap
2.40B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 622.88M | 240.50M | 62.90% |
| Mar 31, 2025 | 382.38M | 30.08M | 8.54% |
| Mar 31, 2024 | 352.30M | 46.48M | 15.20% |
| Mar 31, 2023 | 305.81M | 55.06M | 21.96% |
| Mar 31, 2022 | 250.75M | 65.15M | 35.10% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 8.76B |
| One Global Service Provider | 5.13B |
| Chandan Healthcare | 2.94B |
| Star Imaging and Path Lab | 885.27M |
| Modern Diagnostic & Research Centre | 839.76M |
| Invicta Diagnostic | 330.42M |
| Aspira Pathlab & Diagnostics | 259.03M |
| Clinitech Laboratory | 94.91M |